(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 2605.17 | 2039.88 | 27.71 | 2605.17 | 2039.88 | 27.71 | 10550.71 | 12000.87 | -12.08 |
| Other Income | 130.96 | 136.78 | -4.26 | 130.96 | 136.78 | -4.26 | 527.31 | 444.47 | 18.64 |
| PBIDT | 1002.72 | 750.75 | 33.56 | 1002.72 | 750.75 | 33.56 | 4292.66 | 5507.79 | -22.06 |
| Interest | 0.15 | 0.59 | -74.58 | 0.15 | 0.59 | -74.58 | 2.34 | 5.29 | -55.77 |
| PBDT | 1002.57 | 750.16 | 33.65 | 1002.57 | 750.16 | 33.65 | 4257.57 | 5502.50 | -22.62 |
| Depreciation | 180.47 | 177.76 | 1.52 | 180.47 | 177.76 | 1.52 | 743.25 | 543.74 | 36.69 |
| PBT | 822.10 | 572.40 | 43.62 | 822.10 | 572.40 | 43.62 | 3514.32 | 4958.76 | -29.13 |
| TAX | 210.16 | 146.74 | 43.22 | 210.16 | 146.74 | 43.22 | 881.65 | 1229.11 | -28.27 |
| Deferred Tax | 6.50 | 5.96 | 9.06 | 6.50 | 5.96 | 9.06 | 18.74 | 39.50 | -52.56 |
| PAT | 611.94 | 425.66 | 43.76 | 611.94 | 425.66 | 43.76 | 2632.67 | 3729.65 | -29.41 |
| Equity | 104.62 | 104.62 | 0.00 | 104.62 | 104.62 | 0.00 | 104.62 | 104.62 | 0.00 |
| PBIDTM(%) | 38.49 | 36.80 | 4.58 | 38.49 | 36.80 | 4.58 | 40.69 | 45.89 | -11.35 |
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1882.50 |
| Dr. Reddys Labs. | 1192.00 |
| Cipla | 1430.00 |
| Lupin | 2259.20 |
| Zydus Lifesciences | 1132.00 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: